Your browser doesn't support javascript.
loading
Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.
Isidan, Abdulkadir; Yenigun, Ali; Soma, Daiki; Aksu, Eric; Lopez, Kevin; Park, Yujin; Cross-Najafi, Arthur; Li, Ping; Kundu, Debjyoti; House, Michael G; Chakraborty, Sanjukta; Glaser, Shannon; Kennedy, Lindsey; Francis, Heather; Zhang, Wenjun; Alpini, Gianfranco; Ekser, Burcin.
  • Isidan A; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Yenigun A; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana; Department of General Surgery, Yeditepe University Faculty of Medicine, Istanbul, Turkey.
  • Soma D; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana; Division of Transplantation & Hepatobiliary Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida.
  • Aksu E; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Lopez K; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Park Y; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Cross-Najafi A; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Li P; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Kundu D; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Division of Research, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
  • House MG; Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Chakraborty S; Department of Medical Physiology, Texas A&M University College of Medicine, Bryan, Texas.
  • Glaser S; Department of Medical Physiology, Texas A&M University College of Medicine, Bryan, Texas.
  • Kennedy L; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Division of Research, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
  • Francis H; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Division of Research, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
  • Zhang W; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Alpini G; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Division of Research, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
  • Ekser B; Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: bekser@iupui.edu.
Am J Pathol ; 192(9): 1200-1217, 2022 09.
Article en En | MEDLINE | ID: mdl-35640676
ABSTRACT
Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is associated with late diagnosis, limited treatment options, and a 5-year survival rate of around 30%. CCA cell lines were first established in 1971, and since then, only 70 to 80 CCA cell lines have been established. These cell lines have been essential in basic and translational research to understand and identify novel mechanistic pathways, biomarkers, and disease-specific genes. Each CCA cell line has unique characteristics, reflecting a specific genotype, sex-related properties, and patient-related signatures, making them scientifically and commercially valuable. CCA cell lines are crucial in the use of novel technologies, such as three-dimensional organoid models, which help to model the tumor microenvironment and cell-to-cell crosstalk between tumor-neighboring cells. This review highlights crucial information on CCA cell lines, including i) type of CCA (eg, intra- or extrahepatic), ii) isolation source (eg, primary tumor or xenograft), iii) chemical digestion method (eg, trypsin or collagenase), iv) cell-sorting method (colony isolation or removal of fibroblasts), v) maintenance-medium choice (eg, RPMI or Dulbecco's modified Eagle's medium), vi) cell morphology (eg, spindle or polygonal shape), and vii) doubling time of cells.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article